PEMBROBLAD: Real world effectiveness and safety of immune checkpoint inhibitors in patients with advanced urothelial carcinoma with histological variants.

被引：0
|
作者：
Amrane, Karim
Campedel, Luca
Bennamoun, Mostefa
Gabriel, Pierre-Etienne
Brouchet, Nicolas
Pouessel, Damien
Dugage, Matthieu Roulleaux
Thibault, Constance
Cancel, Mathilde
Gout, Mathilde
Flechon, Aude
Huillard, Olivier
Abbar, Baptiste
Borchiellini, Delphine
Doublet, Louis
Augusto-Pelegrin, Laetitia
Elouen, Boughalem
Moinard-Butot, Fabien
Dumont, Clement
Barthelemy, Philippe
机构：
[1] Oncol Dept, Morlaix, France
[2] CHU Clermont Ferrand, Clermont Ferrand, France
[3] Inst Mutualiste Montsouris, Paris, France
[4] Hop St Louis, Paris, France
[5] IUC Oncopole, Toulouse, France
[6] IUCT Oncopole, Inst Claudius Regaud, Toulouse, France
[7] Hop Europeen Georges Pompidou, Paris, France
[8] Univ Paris Cite, Hop Europeen Georges Pompidou, AP HP Ctr, Inst Canc Paris CARPEM,Dept Pharmacovigilance, Paris, France
[9] Univ Hosp, Dept Med Oncol, Tours, France
[10] Ctr Leon Berard, Lyon, France
[11] Univ Paris Cite, Inst Canc Paris CARPEM, Dept Med Oncol, Hop Cochin,AP HP Ctr, Paris, France
[12] Hop La Pitie Salpetriere, Paris, France
[13] Ctr Antoine Lacassagne, Nice, France
[14] Hop Prive Drome Ardeche, Valence, France
[15] CHU Rouen, Rouen, France
[16] Inst Cancerol Ouest, Angers, France
[17] ICANS Inst Cancerol Strasbourg Europe, Strasbourg, France
[18] APHP Hop St Louis, Paris, France
[19] Inst Cancerol Strasbourg Europe, Med Oncol, Strasbourg, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
261-566-9718-9794; 261-492-3532-2370-7650-2700; 261-492-2769; 613-135-244-3829; 283-9769-3573-426; 7; 3; 2; 242; 2018; 1; 38092-27449; 38092-31019; 38116-38094-8; 5;
D O I：
10.1200/JCO.2024.42.4_suppl.624
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：624 / 624
页数：1
相关论文
共 50 条
  • [1] Immune checkpoint inhibitors as a real hope in advanced urothelial carcinoma
    Seront, Emmanuel
    Catala, Gaetan
    Dermine, Alexandre
    Lejeune, Sarah
    Rysselinck, Stephane
    [J]. FUTURE SCIENCE OA, 2018, 4 (10):
  • [2] Comparative Effectiveness of Immune Checkpoint Inhibitors in Patients with Platinum Refractory Advanced Urothelial Carcinoma
    Swami, Umang
    Haaland, Benjamin
    Kessel, Adam
    Nussenzveig, Roberto
    Maughan, Benjamin Louis
    Esther, John
    Sirohi, Deepika
    Pal, Sumanta K.
    Grivas, Petros
    Agarwal, Neeraj
    [J]. JOURNAL OF UROLOGY, 2021, 205 (03): : 709 - 717
  • [3] Comparative Effectiveness of Immune Checkpoint Inhibitors in Patients with Platinum Refractory Advanced Urothelial Carcinoma COMMENT
    Soleimani, Maryam
    Eigl, Bernhard J.
    [J]. JOURNAL OF UROLOGY, 2021, 205 (03): : 717 - 717
  • [4] The Evolution of Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma
    Houssiau, Helene
    Seront, Emmanuel
    [J]. CANCERS, 2022, 14 (07)
  • [5] Effectiveness and safety of immune checkpoint inhibitor monotherapy in advanced upper tract urothelial carcinoma: A multicenter, retrospective, real-world study
    Su, Ruopeng
    Chen, Zeyu
    Hong, Daoping
    Jiang, Shuai
    Yuan, Yichu
    Cai, Xingyun
    Hu, Hailong
    Fu, Changde
    Huang, Zhiyang
    Wang, Zhenyu
    Zheng, Bing
    Huang, Jian
    Wang, Zaoyu
    Bao, Yige
    Cai, Ming
    Guo, Jianming
    Chen, Minfeng
    Wei, Qiang
    Huang, Jiwei
    Xue, Wei
    [J]. CANCER MEDICINE, 2023, 12 (09): : 10587 - 10596
  • [6] Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma
    Makrakis, Dimitrios
    Bakaloudi, Dimitra Rafailia
    Talukder, Rafee
    Lin, Genevieve Ihsiu
    Diamantopoulos, Leonidas N.
    Jindal, Tanya
    Vather-Wu, Naomi
    Zakharia, Yousef
    Tripathi, Nishita
    Agarwal, Neeraj
    Dawsey, Scott
    Gupta, Shilpa
    Lu, Eric
    Drakaki, Alexandra
    Liu, Sandy
    Zakopoulou, Roubini
    Bamias, Aristotelis
    Fulgenzi, Claudia -Maria
    Cortellini, Alessio
    Pinato, David
    Barata, Pedro
    Grivas, Petros
    Khaki, Ali Raza
    Koshkin, Vadim S.
    [J]. CLINICAL GENITOURINARY CANCER, 2023, 21 (02) : 286 - 294
  • [7] Retrospective study to assess the efficacy and safety of checkpoint inhibitors in advanced urothelial carcinoma in real-world setting.
    Sevillano Fernandez, Elena
    Puente, Javier
    Vidal, Natalia
    Pinto, Alvaro
    Garcia Sanchez, Lourdes
    Fiorini, Aldo
    Chara Velarde, Luis Enrique
    Nalda Ariza, Irene
    Cassinello, Javier
    Rodriguez, Angel
    Galvan Ruiz, Saray
    Francisco Rodriguez-Moreno, Juan
    Barquin, Arantzazu
    Ruiz, Sergio
    Navarro, Paloma
    Yague, Monica
    Grande, Enrique
    Garcia-Donas, Jesus
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Chemotherapy following immune checkpoint inhibitors in patients with locally advanced or metastatic urothelial carcinoma
    Meynard, Lucie
    Dinart, Derek
    Delaunay, Blandine
    Flechon, Aude
    Saldana, Carolina
    Lefort, Felix
    Gravis, Gwenaelle
    Thiery-Vuillemin, Antoine
    Cancel, Mathilde
    Coquan, Elodie
    Ladoire, Sylvain
    Maillet, Denis
    Rolland, Frederic
    Boughalem, Elouen
    Martin, Sophie
    Laramas, Mathieu
    Crouzet, Laurence
    Abbar, Baptiste
    Falkowski, Sabrina
    Pouessel, Damien
    Roubaud, Guilhem
    [J]. EUROPEAN JOURNAL OF CANCER, 2022, 175 : 43 - 53
  • [9] Safety and clinical efficacy of immune checkpoint inhibitors in advanced gastric cancer in the real world
    Hao, Wen
    Liu, Wenjing
    Chang, Ruimin
    Yang, Mi
    Xin, Kai
    Liu, Jingxin
    Wang, Yibing
    Ren, Meijin
    Xie, Jiaqi
    Yang, Yang
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (04)
  • [10] Future Strategies Involving Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma
    Grisay, Guillaume
    Pierrard, Julien
    Confente, Caterina
    Seront, Emmanuel
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (01)
12345